Article

Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach in management of Anemia of Chronic Kidney Disease

2023-06-28

Abstract excerpt

Anemia is a well-developed discipline where the concepts of precision medicine have, in part and being studied extensively. This review discusses the treatment of EPO-deficient anemia and resistance in Chronic Kidney Disease (CKD). Traditionally, erythropoietin-stimulating agents (ESA) and iron supplementation have been used to manage anemia in CKD. However, these treatments have potential risks, including cardiov...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ca3cc031-ee00-59e4-b4ff-ffb15d9473d9
DOI: 10.20944/preprints202306.1893.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach in management of Anemia of Chronic Kidney DiseaseDOI 10.20944/preprints202306.1893.v1Read

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease PatientsSemantic proximity Read

Challenging patient phenotypes in the management of anaemia of chronic kidney disease.Semantic proximity Read

Alteration of the DNA Methylation Signature of Renal Erythropoietin-Producing Cells Governs the Sensitivity to Drugs Targeting the Hypoxia-Response Pathway in Kidney Disease ProgressionSemantic proximity Read

Erythropoietin regulation of red blood cell production: from bench to bedside and backSemantic proximity Read

The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.Semantic proximity Read

Erythropoietin single nucleotide polymorphisms are associated with anemia and dyslipidemia in a cardiovascular disease populationSemantic proximity Read

Molecular Insights into the Oxygen-Sensing Pathway and Erythropoietin Expression Regulation in ErythropoiesisSemantic proximity Read

Role of ACE and IL-1β Gene Polymorphisms in Erythropoeitin Hyporesponsive Patients with Chronic Kidney Disease with Anemia.Semantic proximity Read

HIF-independent actions of HIF-prolyl hydroxylase inhibitors reveal off-target pathways with therapeutic implicationsSemantic proximity Read

Safety of Roxadustat Combined with Epoetin Alfa in Hemodialysis Patients with Anemia: A Cohort StudySemantic proximity Read

Clinically approved HIF‑PHIs modulate redox metabolism, cell growth, and angiogenesis independent of HIF‑1α/HIF‑2αSemantic proximity Read

Erythropoietin in the general population: reference ranges and clinical, biochemical and genetic correlates.Semantic proximity Read